AVITA Medical, Inc. (RCEL) Invested Capital (2023 - 2026)

AVITA Medical (RCEL) has reported Invested Capital for 4 consecutive years, with $18.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Invested Capital fell 41.77% year-over-year to $18.8 million; the trailing twelve-month figure through Jun 2026 stood at $18.8 million (down 41.77% YoY), and the FY2025 full-year result was $26.3 million, down 43.66% from the prior year.
• Invested Capital retreated to $18.8 million in Q2 2026 per RCEL's latest filing, from $26.3 million in the prior quarter.
• Across five years, Invested Capital topped out at $88.9 million in Q4 2023 and bottomed at $18.8 million in Q2 2026.
• Historically, Invested Capital has averaged $48.2 million across 4 years, with a median of $43.3 million in 2024.
• The widest YoY moves for Invested Capital: up 34.67% in 2025, down 50.2% in 2025.
• Over 4 years, Invested Capital stood at $88.9 million in 2023, then plunged by 47.4% to $46.7 million in 2024, then tumbled by 43.66% to $26.3 million in 2025, then dropped by 28.53% to $18.8 million in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $18.8 million, $26.3 million, and $35.8 million for Q2 2026, Q4 2025, and Q3 2025 respectively.